Evidence map›Paper›PMID 27837351›Full record

ReviewJournal of industrial microbiology & biotechnology2017

Biomanufacturing: history and perspective.

Yi-Heng Percival Zhang, Jibin Sun, Yanhe Ma

Abstract readHistorical ArticleReview
PubMed Publisher
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Metabolic Engineering ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. A promoter library for tuning gene expression inFrontiers in bioengineering and biotechnology · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. EngineeringACS catalysis · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-Heng Percival ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Science, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin, 300308, China. zhang_yh@tib.cas.cn.ORCID 0000-0002-4010-2250
Jibin SunTianjin Institute of Industrial Biotechnology, Chinese Academy of Science, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin, 300308, China.
Yanhe MaTianjin Institute of Industrial Biotechnology, Chinese Academy of Science, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin, 300308, China. ma_yh@tib.cas.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomanufacturing is a type of manufacturing that utilizes biological systems (e.g., living microorganisms, resting cells, animal cells, plant cells, tissues, enzymes, or in vitro synthetic (enzymatic) systems) to produce commercially important biomolecules for use in the agricultural, food, material, energy, and pharmaceutical industries. History of biomanufacturing could be classified into the three revolutions in terms of respective product types (mainly), production platforms, and research technologies. Biomanufacturing 1.0 focuses on the production of primary metabolites (e.g., butanol, acetone, ethanol, citric acid) by using mono-culture fermentation; biomanufacturing 2.0 focuses on the production of secondary metabolites (e.g., penicillin, streptomycin) by using a dedicated mutant and aerobic submerged liquid fermentation; and biomanufacturing 3.0 focuses on the production of large-size biomolecules-proteins and enzymes (e.g., erythropoietin, insulin, growth hormone, amylase, DNA polymerase) by using recombinant DNA technology and advanced cell culture. Biomanufacturing 4.0 could focus on new products, for example, human tissues or cells made by regenerative medicine, artificial starch made by in vitro synthetic biosystems, isobutanol fermented by metabolic engineering, and synthetic biology-driven microorganisms, as well as exiting products produced by far better approaches. Biomanufacturing 4.0 would help address some of the most important challenges of humankind, such as food security, energy security and sustainability, water crisis, climate change, health issues, and conflict related to the energy, food, and water nexus.

Indexed as

AnimalsBioreactorsBiotechnologyFermentationHistory, 18th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansMetabolic EngineeringRecombinant ProteinsRegenerative MedicineSynthetic BiologyRecombinant ProteinsAdvanced biomanufacturingBioeconomyBiomanufacturing 4.0In vitro synthetic biosystemMetabolic engineering and synthetic biologySustainability revolution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.